PARNAX LAB
Back to Cashflow Statement
|
PARNAX LAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-16 Cr | ₹15 Cr | ₹-14 Cr | ₹12 Cr | ₹0.05 Cr |
What is the latest Cash Flow from Financing Activities ratio of PARNAX LAB ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-16 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹-14 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹0.05 Cr |
How is Cash Flow from Financing Activities of PARNAX LAB Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-16 Cr | Negative | |
| Mar2024 | ₹15 Cr | Positive | |
| Mar2023 | ₹-14 Cr | Negative | |
| Mar2022 | ₹12 Cr | 23,692.16 | |
| Mar2021 | ₹0.05 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹141.0 Cr | 2.2% | -0.3% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 2.2% |
-0.3% |
32.7% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses